Form 4 holding
Chief Financial Officer
Kailera Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 100,000
- Estimated value
- Report date
- 16 Apr 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount